Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
Submitted by
admin
on March 25, 2016 - 9:41am
Source:
Seeking Alpha
News Tags:
Amgen
patents
patent cliff
Headline:
40% Of Amgen Sales Are Due To Fall Off The Patent Cliff
Do Not Allow Advertisers to Use My Personal information
